101 research outputs found
A fekélybetegség és a stressz
The discovery that Helicobacter pylori infection is the major cause of peptic ulcer disease revolutionised our views on the etiology and treatment of the disease. This discovery has tempted many experts to conclude that psychological factors and, specifically, stress are unimportant. However, Helicobacter pylori infection alone does not explain fully the incidence and prevalence of peptic ulcer disease. It has been demonstrated that stress can cause peptic ulcer disease even in the absence of Helicobacter pylori infection, supporting a multicausal model of peptic ulcer etiology. Psychological stress among other risk factors can function as a cofactor with Helicobacter pylori infection. Orv. Hetil., 2015, 156(35), 1426-1429
Implications of growth factor alterations in the treatment of pancreatic cancer
Pancreatic cancer ranks fifth as a cause of cancer-related death in the world with an overall 5-year survival rate of less than 1% and a median survival of less than a year after tumour detection. Most of these patients have already metastases at the time of diagnosis. The oncologic strategies such as chemotherapy, radiotherapy, antihormonal modalities or the systemic use of specific monoclonal antibodies have not achieved a significant improvement in the survival of pancreatic cancer patients. Recent studies suggest that alterations in molecular pathways, particularly in growth factor mediated mechanisms, that regulate cell proliferation and differentiation play a pivotal role in the pathogenesis of this cancer. The molecular knowledge regarding changes in the expression of growth factors in pancreatic cancer has the potential to improve diagnostic and therapeutic treatment strategies in the near future
Intenzív cseresznyeültetvény, mint mesterséges ökoszisztéma és biológiailag aktív felület értékelése CO2 megkötés és vízhasznosulás szempontjából
Munkánk célja az volt, hogy műszeres vizsgálatokkal pontosabb adatokat nyerjünk az intenzív cseresznyeültetvények levélzetének fotoszintetikus aktivitásáról és transzspirációjáról, melyek felhasználásával becsülni lehet gyümölcstermő ültetvények, mint jelentős biológiailag aktív zöldfelületek hozzájárulását és szerepét a légkör CO2 tartalmának megkötéséhez. Adatainkkal pontosítani lehet az ültetvények vízfelhasználására vonatkozó ismereteket is
Gastritisek es gastropathiak.
Alterations of the stomach mucosa in response to different adverse effects result in various morphological and clinical symptoms. Gastric mucosa alterations can be classified on the bases of diverse viewpoints. It makes this overview difficult, that identical toxic effects may cause different mucosal changes and different toxic agents may produce similar mucosal appearance. The more accurate understanding of the pathological processes which develop in the stomach mucosa needs reconsideration. The authors make an attempt to define gastritis and gastropathy in order to classify and present their features. Gastritis is a histological definition indicating mucosal inflammation. Acute gastritis is caused by infections. The two most important forms of chronic gastritis are metaplastic atrophic gastritis with an autoimmune origin and Helicobacter pylori inflammation. Gastropathy is the name of different structural alterations of the mucosa. Its most important feature is the paucity of inflammatory signs. Gastropathies can be divided into 4 categories based on the nature of the underlying pathological effect, on its morphological appearance and the way of the development. Differential diagnosis is an important pathological and clinical task because different treatment methods and prognosis. Orv. Hetil., 2014, 155(2), 43-61
Eosinophil oesophagitis étrendi és gyógyszeres vonatkozásai
Eosinophilic esophagitis is considered to be a chronic antigen-driven disease whereby food and/or aeroallergens induce a chronic inflammatory infiltrate in the esophagus leading to pathological hyperplasia of the epithelial and muscular layers, fibrosis of the lamina propria and symptoms of dysphagia and food impaction. Eosinophilic esophagitis is often associated with other allergic diseases such as asthma or atopic dermatitis. Current first line treatments of the disease include strict dietary modification and topical anti-inflammatory steroids. In this review the authors summarize currently available treatment strategies of eosinophilic esophagitis
Admission risk factors and predictors of moderate or severe pediatric acute pancreatitis: A systematic review and meta-analysis
Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis
AIM: To investigate the role of glutathione S-transferase (GST) and
matrix meta lloproteinase-9 (MMP-9) expressions in the development and
progression of reflux esophagitis-Barrett's meta
plasia-dysplasia-adenocarcinoma sequence in the esophagus.
METHODS: GST and MMP-9 expressions were analyzed in 51
paraffin-embedded tissue samples by immunohistochemistry including
patients with reflux esophagitis (n = 7), Barrett's metaplasia (n =
14), Barrett and esophagitis (n = 8), Barrett and dysplasia (n = 7),
esophageal adenocarcinoma (n = 8) and a control group without any
histological changes (n = 7). Immunostaining was determined
semiquantitatively. Statistical analysis with one-way ANOVA, LSD test
and correlation analysis were performed. P value of < 0.05 was
considered significant.
RESULTS: GST expression was significantly higher while MMP-9 expression
was significantly lower in control group compared to Barrett's
metaplasia and the other groups. No major changes were observed between
Barrett, esophagitis, and Barrett and concomitant esophagitis. Barrett
and concomitant dysplasia, and adenocardnoma revealed a significant
lower expression of GST and higher levels of MMP-9 compared to all
other groups. Adenocarcinoma showed almost no expression of GST and
significantly higher levels of MMP-9 than Barrett and concomitant
dysplasia. Alterations of GST and MMP-9 were inversely correlated (r
0.82).
CONCLUSION: Decreased GST and increased expression of MMP-9 in
Barrett's meta plasia-clysplasiaadenocarcinoma sequence as compared to
normal tissue suggest their association with esophageal tumorigenesis.
Loss of GST and gain of MMP-9 in Barrett with dysplasia compared to
non-clysplastic metaplasia indicate that these alterations may be early
events in carcinogenesis. Quantification of these parameters in
Barrett's esophagus might be useful to identify patients at higher risk
for progression to cancer. (c) 2007 The WJG Press. All rights reserved
A coeliakia genetikai es epigenetikai vonatkozasai.
Genetic backround of coeliac disease has been subjects to intensive research since decades. However, only results of HLA phenotyping have been taken over to routine clinical practice. Meanwhile, data on the role of epigenetical factors in the manifestation of diseases have been emerging. In coeliac disease, there are several questions both in the fields of genetics and epigenetics yet to be answered. In this review, a cross section of current knowledge on these issues is presented with special interest regarding the future clinical applications. Orv. Hetil., 2014, 155(3), 83-88
The Impact of Trimetazidine on Disease Severity and Quality of Life in Parkinson's Disease
Trimetazidine is contraindicated in movement disorders, however, a not negligible part of trimetazidine users is still patients with Parkinson's disease (PD). The present study aimed to objectively determine the impact of trimetazidine on the severity of symptoms and the health-related quality of life of patients with PD by measuring changes after its withdrawal. A consecutive series of 42 patients with PD using trimetazidine underwent detailed neurological and neuropsychological assessments at baseline and three months after the discontinuation of trimetazidine. Clinically relevant improvements were achieved with discontinuation of trimetazidine according to changes in scores of each part of the Movement Disorder Society-sponsored Unified Parkinson's Disease Rating Scale (Part I: -25.7%, p < 0.001; Part II: -23.8%, p < 0.001; Part III: -28.5%, p < 0.001; Part IV: -30.1%, p = 0.004) and total scores of the Non-Motor Symptoms Scale (-25.6%, p = 0.004) and the Montgomery-Asberg-Depression Rating Scale (-20.1%, p = 0.001). Benefits resulting from the withdrawal of the drug also manifested in the improvement of the health-related quality of life based on changes in the summary index of the 39-item Parkinson's Disease Questionnaire (-18.2%, p = 0.031). Our results provide clinical rationale for strictly avoiding the use of trimetazidine in PD. Discontinuation of trimetazidin results in clinically relevant improvements in Parkinsonian symptoms
- …